Page 13 - Ampe D News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ampe d. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ampe D Today - Breaking & Trending Today

StockNews.com Begins Coverage on Ampio Pharmaceuticals (NYSEAMERICAN:AMPE)

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Get Rating) in a research report released on Tuesday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Trading Up 3.2 % Shares of Ampio Pharmaceuticals stock opened at $0.26 on Tuesday. Ampio Pharmaceuticals has a twelve month low […] ....

Ampio Pharmaceuticals Inc , Ampio Pharmaceuticals Trading , Pricet Rowe Associates Inc , Ampio Pharmaceuticals , News Ratings For Ampio Pharmaceuticals Daily , Virtu Financial , Institutional Trading Of Ampio Pharmaceuticals , Get Rating , Sigma Advisers , Montreal Can , Ampio Pharmaceuticals Daily , Nyseamerican Ampe , Initiated Coverage , Stocknews Com ,

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Get Rating) in a report published on Sunday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Stock Performance Shares of NYSEAMERICAN AMPE opened at $0.25 on Friday. The firm has a market capitalization of $3.83 million, a P/E ratio […] ....

Ampio Pharmaceuticals Stock Performance , Ampio Pharmaceuticals Inc , Pricet Rowe Associates Inc , Virtu Financial , Ampio Pharmaceuticals , News Ratings For Ampio Pharmaceuticals Daily , Get Rating , Montreal Can , Two Sigma Advisers , Sigma Advisers , Ampio Pharmaceuticals Daily , Nyseamerican Ampe , Initiated Coverage , Stocknews Com ,

Ampio Pharmaceuticals (NYSE:AMPE) Research Coverage Started at StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Rating) in a research note issued on Sunday. The brokerage set a “sell” rating on the stock. Ampio Pharmaceuticals Stock Performance About Ampio Pharmaceuticals (Get Rating) Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It […] ....

United States , Ampio Pharmaceuticals Stock Performance , News Ratings For Ampio Pharmaceuticals Daily , Ampio Pharmaceuticals , Ampio Pharmaceuticals Inc , Get Rating , Ampio Pharmaceuticals Daily , Nyse Ampe , Initiated Coverage , Stocknews Com ,

StockNews.com Begins Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

Equities researchers at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Rating) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the stock. Ampio Pharmaceuticals Stock Performance About Ampio Pharmaceuticals (Get Rating) Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. […] ....

United States , Ampio Pharmaceuticals Stock Performance , Ampio Pharmaceuticals , Ampio Pharmaceuticals Inc , News Ratings For Ampio Pharmaceuticals Daily , Get Rating , Ampio Pharmaceuticals Daily , Nyse Ampe , Initiated Coverage , Stocknews Com ,

StockNews.com Begins Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Rating) in a research report sent to investors on Thursday morning. The firm issued a sell rating on the stock. Ampio Pharmaceuticals Stock Up 5.5 % Shares of AMPE opened at $0.29 on Thursday. Ampio Pharmaceuticals has a 1 year low of $0.18 and […] ....

News Ratings For Ampio Pharmaceuticals Daily , Ampio Pharmaceuticals , Ampio Pharmaceuticals Inc , Ampio Pharmaceuticals Company Profile , Ampio Pharmaceuticals Stock , Get Rating , Ampio Pharmaceuticals Daily , Nyse Ampe , Initiated Coverage , Stocknews Com ,